Wells Fargo & Company Raises KKR & Co. Inc. (NYSE:KKR) Price Target to $152.00

KKR & Co. Inc. (NYSE:KKR) had its price target raised by Wells Fargo & Company from $139.00 to $152.00 in a research report report published on Friday, Benzinga reports. The brokerage currently has an equal weight rating on the asset manager’s stock.

Several other equities research analysts have also weighed in on the company. Oppenheimer increased their target price on KKR & Co. Inc. from $128.00 to $148.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 16th. Citigroup increased their price objective on shares of KKR & Co. Inc. from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Friday, August 2nd. Morgan Stanley boosted their target price on shares of KKR & Co. Inc. from $107.00 to $143.00 and gave the company an “equal weight” rating in a research note on Thursday, October 10th. HSBC started coverage on KKR & Co. Inc. in a report on Wednesday, September 18th. They set a “buy” rating and a $148.00 price target on the stock. Finally, JMP Securities boosted their price objective on KKR & Co. Inc. from $135.00 to $150.00 and gave the stock a “market outperform” rating in a research report on Wednesday, October 9th. One investment analyst has rated the stock with a sell rating, two have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, KKR & Co. Inc. presently has an average rating of “Moderate Buy” and an average price target of $151.29.

KKR & Co. Inc. Trading Down 2.4 %

NYSE KKR opened at $139.88 on Friday. The firm has a market capitalization of $124.14 billion, a PE ratio of 32.99, a price-to-earnings-growth ratio of 1.20 and a beta of 1.62. KKR & Co. Inc. has a one year low of $53.72 and a one year high of $147.15. The company has a 50-day simple moving average of $128.49 and a 200-day simple moving average of $114.00. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.07 and a current ratio of 0.07.

KKR & Co. Inc. (NYSE:KKR) last issued its earnings results on Thursday, October 24th. The asset manager reported $1.38 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.35. The company had revenue of $4.79 billion during the quarter, compared to the consensus estimate of $1.23 billion. KKR & Co. Inc. had a return on equity of 5.05% and a net margin of 17.99%. During the same period in the previous year, the firm posted $0.73 earnings per share. On average, equities analysts forecast that KKR & Co. Inc. will post 3.97 earnings per share for the current year.

KKR & Co. Inc. Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, November 19th. Shareholders of record on Monday, November 4th will be given a $0.175 dividend. This represents a $0.70 annualized dividend and a yield of 0.50%. The ex-dividend date is Monday, November 4th. KKR & Co. Inc.’s dividend payout ratio (DPR) is presently 16.51%.

Insider Buying and Selling at KKR & Co. Inc.

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the transaction, the insider now owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, major shareholder Kkr Group Partnership L.P. purchased 11,619,998 shares of the firm’s stock in a transaction that occurred on Wednesday, September 11th. The stock was acquired at an average price of $11.13 per share, for a total transaction of $129,330,577.74. Following the transaction, the insider now directly owns 92,959,984 shares of the company’s stock, valued at $1,034,644,621.92. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of KKR & Co. Inc. stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $25.75, for a total value of $149,350,000.00. Following the completion of the transaction, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 39.34% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in KKR. Versant Capital Management Inc lifted its position in shares of KKR & Co. Inc. by 622.9% in the 2nd quarter. Versant Capital Management Inc now owns 253 shares of the asset manager’s stock valued at $27,000 after acquiring an additional 218 shares in the last quarter. Mather Group LLC. raised its stake in KKR & Co. Inc. by 371.4% during the 2nd quarter. Mather Group LLC. now owns 264 shares of the asset manager’s stock valued at $27,000 after purchasing an additional 208 shares during the period. ORG Wealth Partners LLC purchased a new stake in shares of KKR & Co. Inc. in the third quarter valued at $31,000. Raleigh Capital Management Inc. boosted its position in shares of KKR & Co. Inc. by 56.7% in the third quarter. Raleigh Capital Management Inc. now owns 235 shares of the asset manager’s stock worth $31,000 after buying an additional 85 shares during the period. Finally, Eastern Bank purchased a new position in shares of KKR & Co. Inc. during the third quarter valued at $34,000. 76.26% of the stock is currently owned by institutional investors and hedge funds.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.